A thrombotic risk score was proposed in the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events–Thrombolysis in Myocardial Infarction 50 trial (22), which included ischemic stroke as a TE; age was the common independent predictor of TEs in that previous study. This evidence concerns the gene F2R and ischemic stroke.